Value-Based Care

A new bispecific antibody, TRIV-573, enters clinical trials, targeting both skin barrier and inflammation to redefine atopic dermatitis therapy.

Beyond fat removal, a new wave of cosmetic surgery in Dubai uses advanced tech to craft athletic, natural bodies, making the city a global beauty hub.

Hong Kong's PolyU is leading a global charge, uniting scientists and masters to prove the medical power of Tai Chi and Qigong.

Industry veteran Steve Motes joins Tulyp Medical as CEO, aiming to commercialize a revolutionary pressure-driven perfusion system with a proven team.

A groundbreaking surgical technique in Gujarat eliminates neck scars, offering new hope and faster recovery for millions with thyroid conditions.

A tuition-free 'earn-and-learn' model in San Francisco offers a lifeline, turning kitchen staff into skilled nurses to combat a deepening caregiver shortage.

A new state partnership introduces a home-based treatment model, aiming to heal families and keep mothers with their children amid a worsening substance use crisis.

A new partnership offers a turnkey imaging system for medical device makers, aiming to slash development time and enhance surgical precision in arthroscopy.

FDA clears Allevion's Vantage™, a disposable kit with integrated visualization that targets bone growth, aiming to transform spinal decompression.

A global health leader is running for Congress in a crowded NYC primary, betting her scientific expertise can beat traditional politics.

Pantai Hospital KL's spot on Newsweek's 'World's Best' list highlights a national strategy built on superior quality, patient trust, and medical tourism.

Merz Aesthetics secures key EU approvals for its BELOTERO® Balance filler, offering a precise, evidence-backed solution for tired eyes and forehead lines.

With a massive new investment led by NewSpring, physician-led Honest Health is set to expand its mission of transforming healthcare from volume to value.

Japan becomes the first nation outside Israel to approve Alpha DaRT, a highly precise therapy for untreatable head and neck cancers. Here’s what it means.

Verdiva Bio's VRB-101 aims to be the first once-weekly oral GLP-1, a potential game-changer for patients tired of daily pills and injections.

Fresh off strong 2025 earnings, AtriCure will detail its growth strategy and innovative cardiac portfolio at a major life sciences conference.

A pivotal trial for a rare muscle disease failed its main goal, but promising data in a specific patient group offers a new, complex path forward.

With its Moda-flx system cleared by the FDA, Diality hires M&A expert Peter Donato to navigate the path to commercialization in the $92B dialysis market.

As Legacy Community Health embarks on a historic expansion, new COO Aaron Stewart is tasked with steering Texas's largest FQHC to serve more communities.

The AI health platform's latest acquisition integrates a specialized pregnancy app, promising a new era of proactive, data-driven maternal care for families.